Adverse event after influenza vaccine | ||||||
---|---|---|---|---|---|---|
Total | No AE | Local AE only | Systemic AE | Recurrent systemic AE | p-value | |
Overall | 386 (100.0)a | 287 (74.4) | 29 (7.5) | 48 (12.4) | 22 (5.7) | |
Invitation Mode | ||||||
218 (56.5) | 153 (70.2) | 15 (6.9) | 34 (15.6) | 16 (7.3) | ||
Post | 168 (43.5) | 134 (79.8) | 14 (8.3) | 14 (8.3) | 6 (3.6) | 0.05 |
Length | ||||||
Short version | 180 (46.6) | 121 (67.2) | 18 (10.0) | 31 (17.2) | 10 (5.6) | |
Longer version | 206 (53.4) | 166 (80.6) | 11 (5.3) | 17 (8.3) | 12 (5.8) | 0.01 |
Format | ||||||
Closed-ended | 187 (48.4) | 141 (75.1) | 15 (8.0) | 18 (9.6) | 13 (7.0) | |
Open-ended | 199 (51.6) | 146 (73.4) | 14 (7.0) | 30 (15.1) | 9 (4.5) | 0.32 |
Ageb | ||||||
18–49 yrs | 155 (40.3) | 106 (68.4) | 11 (7.1) | 28 (18.1) | 10 (6.5) | |
≥ 50 yrs | 230 (59.7) | 180 (78.3) | 18 (7.8) | 20 (8.7) | 12 (5.2) | 0.05 |
Sex | ||||||
Female | 303 (78.5) | 224 (74.0) | 23 (7.6) | 35 (11.6) | 21 (6.9) | |
Male | 83 (21.5) | 63 (75.9) | 6 (7.2) | 13 (15.7) | 1 (1.2) | 0.17 |
Ageb and Sex | ||||||
Female 18–49 yrs | 123 (32.0) | 85 (69.1) | 9 (7.3) | 19 (15.5) | 10 (8.1) | |
Male 18–49 yrs | 32 (8.3) | 21 (65.6) | 2 (6.3) | 9 (28.1) | 0 | |
Female ≥50 yrs | 180 (46.8) | 139 (77.2) | 14 (7.8) | 16 (8.9) | 11 (6.1) | |
Male ≥50 yrs | 50 (13.0) | 41 (82.0) | 4 (8.0) | 4 (8.0) | 1 (2.0) | 0.11 |
AE after non-influenza vaccines | ||||||
Yes | 58 (15.0) | 33 (56.9) | 11 (19.0) | 7 (12.1) | 7 (12.1) | |
No | 248 (64.3) | 208 (83.9) | 10 (4.0) | 21 (8.5) | 9 (3.6) | |
Don’t recall/No answer | 80 (20.7) | 46 (57.5) | 8 (10.0) | 20 (25.0) | 6 (7.5) | < 0.001 |